Global Gene-based Therapy Medicinal Supply, Demand and Key Producers, 2023-2029
The global Gene-based Therapy Medicinal market size is expected to reach $ 44180 million by 2029, rising at a market growth of 24.9% CAGR during the forecast period (2023-2029).
The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
This report studies the global Gene-based Therapy Medicinal demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene-based Therapy Medicinal, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene-based Therapy Medicinal that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene-based Therapy Medicinal total market, 2018-2029, (USD Million)
Global Gene-based Therapy Medicinal total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gene-based Therapy Medicinal total market, key domestic companies and share, (USD Million)
Global Gene-based Therapy Medicinal revenue by player and market share 2018-2023, (USD Million)
Global Gene-based Therapy Medicinal total market by Type, CAGR, 2018-2029, (USD Million)
Global Gene-based Therapy Medicinal total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Gene-based Therapy Medicinal market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene-based Therapy Medicinal market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene-based Therapy Medicinal Market, By Region:
1. How big is the global Gene-based Therapy Medicinal market?
2. What is the demand of the global Gene-based Therapy Medicinal market?
3. What is the year over year growth of the global Gene-based Therapy Medicinal market?
4. What is the total value of the global Gene-based Therapy Medicinal market?
5. Who are the major players in the global Gene-based Therapy Medicinal market?
The gene-based therapy medicinal market is driven by the potential for revolutionary treatments by targeting genetic disorders at their source. These therapies offer hope for conditions with no existing cures. However, a significant challenge is the complexity of gene-based therapies and the need for rigorous clinical trials to prove safety and efficacy. Regulatory approvals and high development costs pose challenges for manufacturers. Additionally, market competition and pricing concerns necessitate a balance between accessibility and recovering research and development investments. The gene-based therapy market holds promise but faces hurdles in delivering groundbreaking treatments while addressing scientific, regulatory, and economic challenges.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
This report studies the global Gene-based Therapy Medicinal demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene-based Therapy Medicinal, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene-based Therapy Medicinal that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene-based Therapy Medicinal total market, 2018-2029, (USD Million)
Global Gene-based Therapy Medicinal total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gene-based Therapy Medicinal total market, key domestic companies and share, (USD Million)
Global Gene-based Therapy Medicinal revenue by player and market share 2018-2023, (USD Million)
Global Gene-based Therapy Medicinal total market by Type, CAGR, 2018-2029, (USD Million)
Global Gene-based Therapy Medicinal total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Gene-based Therapy Medicinal market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene-based Therapy Medicinal market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene-based Therapy Medicinal Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Viral Gene Delivery System
- Non-viral Gene Delivery System
- Neurological Diseases
- Cancer
- Other
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
1. How big is the global Gene-based Therapy Medicinal market?
2. What is the demand of the global Gene-based Therapy Medicinal market?
3. What is the year over year growth of the global Gene-based Therapy Medicinal market?
4. What is the total value of the global Gene-based Therapy Medicinal market?
5. Who are the major players in the global Gene-based Therapy Medicinal market?
1 SUPPLY SUMMARY
1.1 Gene-based Therapy Medicinal Introduction
1.2 World Gene-based Therapy Medicinal Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Gene-based Therapy Medicinal Total Market by Region (by Headquarter Location)
1.3.1 World Gene-based Therapy Medicinal Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.3 China Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.4 Europe Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.5 Japan Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.6 South Korea Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.7 ASEAN Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.8 India Gene-based Therapy Medicinal Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene-based Therapy Medicinal Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene-based Therapy Medicinal Major Market Trends
2 DEMAND SUMMARY
2.1 World Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.2 World Gene-based Therapy Medicinal Consumption Value by Region
2.2.1 World Gene-based Therapy Medicinal Consumption Value by Region (2018-2023)
2.2.2 World Gene-based Therapy Medicinal Consumption Value Forecast by Region (2024-2029)
2.3 United States Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.4 China Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.5 Europe Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.6 Japan Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.7 South Korea Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.8 ASEAN Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.9 India Gene-based Therapy Medicinal Consumption Value (2018-2029)
3 WORLD GENE-BASED THERAPY MEDICINAL COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene-based Therapy Medicinal Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene-based Therapy Medicinal Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene-based Therapy Medicinal in 2022
3.2.3 Global Concentration Ratios (CR8) for Gene-based Therapy Medicinal in 2022
3.3 Gene-based Therapy Medicinal Company Evaluation Quadrant
3.4 Gene-based Therapy Medicinal Market: Overall Company Footprint Analysis
3.4.1 Gene-based Therapy Medicinal Market: Region Footprint
3.4.2 Gene-based Therapy Medicinal Market: Company Product Type Footprint
3.4.3 Gene-based Therapy Medicinal Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene-based Therapy Medicinal Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene-based Therapy Medicinal Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Gene-based Therapy Medicinal Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Gene-based Therapy Medicinal Consumption Value Comparison
4.2.1 United States VS China: Gene-based Therapy Medicinal Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene-based Therapy Medicinal Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Gene-based Therapy Medicinal Companies and Market Share, 2018-2023
4.3.1 United States Based Gene-based Therapy Medicinal Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023)
4.4 China Based Companies Gene-based Therapy Medicinal Revenue and Market Share, 2018-2023
4.4.1 China Based Gene-based Therapy Medicinal Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023)
4.5 Rest of World Based Gene-based Therapy Medicinal Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Gene-based Therapy Medicinal Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene-based Therapy Medicinal Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Viral Gene Delivery System
5.2.2 Non-viral Gene Delivery System
5.3 Market Segment by Type
5.3.1 World Gene-based Therapy Medicinal Market Size by Type (2018-2023)
5.3.2 World Gene-based Therapy Medicinal Market Size by Type (2024-2029)
5.3.3 World Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene-based Therapy Medicinal Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Neurological Diseases
6.2.2 Cancer
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Gene-based Therapy Medicinal Market Size by Application (2018-2023)
6.3.2 World Gene-based Therapy Medicinal Market Size by Application (2024-2029)
6.3.3 World Gene-based Therapy Medicinal Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Biogen
7.1.1 Biogen Details
7.1.2 Biogen Major Business
7.1.3 Biogen Gene-based Therapy Medicinal Product and Services
7.1.4 Biogen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Biogen Recent Developments/Updates
7.1.6 Biogen Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Gene-based Therapy Medicinal Product and Services
7.2.4 Novartis Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Gilead Sciences
7.3.1 Gilead Sciences Details
7.3.2 Gilead Sciences Major Business
7.3.3 Gilead Sciences Gene-based Therapy Medicinal Product and Services
7.3.4 Gilead Sciences Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Gilead Sciences Recent Developments/Updates
7.3.6 Gilead Sciences Competitive Strengths & Weaknesses
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Details
7.4.2 Sarepta Therapeutics Major Business
7.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Product and Services
7.4.4 Sarepta Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sarepta Therapeutics Recent Developments/Updates
7.4.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Details
7.5.2 Alnylam Pharmaceuticals Major Business
7.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product and Services
7.5.4 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.5.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Amgen
7.6.1 Amgen Details
7.6.2 Amgen Major Business
7.6.3 Amgen Gene-based Therapy Medicinal Product and Services
7.6.4 Amgen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Amgen Recent Developments/Updates
7.6.6 Amgen Competitive Strengths & Weaknesses
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Details
7.7.2 Spark Therapeutics Major Business
7.7.3 Spark Therapeutics Gene-based Therapy Medicinal Product and Services
7.7.4 Spark Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Spark Therapeutics Recent Developments/Updates
7.7.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Details
7.8.2 Akcea Therapeutics Major Business
7.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Product and Services
7.8.4 Akcea Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Akcea Therapeutics Recent Developments/Updates
7.8.6 Akcea Therapeutics Competitive Strengths & Weaknesses
7.9 Sunway Biotech
7.9.1 Sunway Biotech Details
7.9.2 Sunway Biotech Major Business
7.9.3 Sunway Biotech Gene-based Therapy Medicinal Product and Services
7.9.4 Sunway Biotech Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Sunway Biotech Recent Developments/Updates
7.9.6 Sunway Biotech Competitive Strengths & Weaknesses
7.10 SIBIONO
7.10.1 SIBIONO Details
7.10.2 SIBIONO Major Business
7.10.3 SIBIONO Gene-based Therapy Medicinal Product and Services
7.10.4 SIBIONO Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 SIBIONO Recent Developments/Updates
7.10.6 SIBIONO Competitive Strengths & Weaknesses
7.11 AnGes
7.11.1 AnGes Details
7.11.2 AnGes Major Business
7.11.3 AnGes Gene-based Therapy Medicinal Product and Services
7.11.4 AnGes Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 AnGes Recent Developments/Updates
7.11.6 AnGes Competitive Strengths & Weaknesses
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Details
7.12.2 Orchard Therapeutics Major Business
7.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Product and Services
7.12.4 Orchard Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Orchard Therapeutics Recent Developments/Updates
7.12.6 Orchard Therapeutics Competitive Strengths & Weaknesses
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Details
7.13.2 Human Stem Cells Institute Major Business
7.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Product and Services
7.13.4 Human Stem Cells Institute Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Human Stem Cells Institute Recent Developments/Updates
7.13.6 Human Stem Cells Institute Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene-based Therapy Medicinal Industry Chain
8.2 Gene-based Therapy Medicinal Upstream Analysis
8.3 Gene-based Therapy Medicinal Midstream Analysis
8.4 Gene-based Therapy Medicinal Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Gene-based Therapy Medicinal Introduction
1.2 World Gene-based Therapy Medicinal Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Gene-based Therapy Medicinal Total Market by Region (by Headquarter Location)
1.3.1 World Gene-based Therapy Medicinal Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.3 China Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.4 Europe Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.5 Japan Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.6 South Korea Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.7 ASEAN Gene-based Therapy Medicinal Market Size (2018-2029)
1.3.8 India Gene-based Therapy Medicinal Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene-based Therapy Medicinal Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene-based Therapy Medicinal Major Market Trends
2 DEMAND SUMMARY
2.1 World Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.2 World Gene-based Therapy Medicinal Consumption Value by Region
2.2.1 World Gene-based Therapy Medicinal Consumption Value by Region (2018-2023)
2.2.2 World Gene-based Therapy Medicinal Consumption Value Forecast by Region (2024-2029)
2.3 United States Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.4 China Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.5 Europe Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.6 Japan Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.7 South Korea Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.8 ASEAN Gene-based Therapy Medicinal Consumption Value (2018-2029)
2.9 India Gene-based Therapy Medicinal Consumption Value (2018-2029)
3 WORLD GENE-BASED THERAPY MEDICINAL COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene-based Therapy Medicinal Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene-based Therapy Medicinal Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene-based Therapy Medicinal in 2022
3.2.3 Global Concentration Ratios (CR8) for Gene-based Therapy Medicinal in 2022
3.3 Gene-based Therapy Medicinal Company Evaluation Quadrant
3.4 Gene-based Therapy Medicinal Market: Overall Company Footprint Analysis
3.4.1 Gene-based Therapy Medicinal Market: Region Footprint
3.4.2 Gene-based Therapy Medicinal Market: Company Product Type Footprint
3.4.3 Gene-based Therapy Medicinal Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene-based Therapy Medicinal Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene-based Therapy Medicinal Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Gene-based Therapy Medicinal Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Gene-based Therapy Medicinal Consumption Value Comparison
4.2.1 United States VS China: Gene-based Therapy Medicinal Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene-based Therapy Medicinal Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Gene-based Therapy Medicinal Companies and Market Share, 2018-2023
4.3.1 United States Based Gene-based Therapy Medicinal Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023)
4.4 China Based Companies Gene-based Therapy Medicinal Revenue and Market Share, 2018-2023
4.4.1 China Based Gene-based Therapy Medicinal Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023)
4.5 Rest of World Based Gene-based Therapy Medicinal Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Gene-based Therapy Medicinal Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene-based Therapy Medicinal Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Viral Gene Delivery System
5.2.2 Non-viral Gene Delivery System
5.3 Market Segment by Type
5.3.1 World Gene-based Therapy Medicinal Market Size by Type (2018-2023)
5.3.2 World Gene-based Therapy Medicinal Market Size by Type (2024-2029)
5.3.3 World Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene-based Therapy Medicinal Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Neurological Diseases
6.2.2 Cancer
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Gene-based Therapy Medicinal Market Size by Application (2018-2023)
6.3.2 World Gene-based Therapy Medicinal Market Size by Application (2024-2029)
6.3.3 World Gene-based Therapy Medicinal Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Biogen
7.1.1 Biogen Details
7.1.2 Biogen Major Business
7.1.3 Biogen Gene-based Therapy Medicinal Product and Services
7.1.4 Biogen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Biogen Recent Developments/Updates
7.1.6 Biogen Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Gene-based Therapy Medicinal Product and Services
7.2.4 Novartis Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Gilead Sciences
7.3.1 Gilead Sciences Details
7.3.2 Gilead Sciences Major Business
7.3.3 Gilead Sciences Gene-based Therapy Medicinal Product and Services
7.3.4 Gilead Sciences Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Gilead Sciences Recent Developments/Updates
7.3.6 Gilead Sciences Competitive Strengths & Weaknesses
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Details
7.4.2 Sarepta Therapeutics Major Business
7.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Product and Services
7.4.4 Sarepta Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sarepta Therapeutics Recent Developments/Updates
7.4.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Details
7.5.2 Alnylam Pharmaceuticals Major Business
7.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product and Services
7.5.4 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
7.5.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Amgen
7.6.1 Amgen Details
7.6.2 Amgen Major Business
7.6.3 Amgen Gene-based Therapy Medicinal Product and Services
7.6.4 Amgen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Amgen Recent Developments/Updates
7.6.6 Amgen Competitive Strengths & Weaknesses
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Details
7.7.2 Spark Therapeutics Major Business
7.7.3 Spark Therapeutics Gene-based Therapy Medicinal Product and Services
7.7.4 Spark Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Spark Therapeutics Recent Developments/Updates
7.7.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Details
7.8.2 Akcea Therapeutics Major Business
7.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Product and Services
7.8.4 Akcea Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Akcea Therapeutics Recent Developments/Updates
7.8.6 Akcea Therapeutics Competitive Strengths & Weaknesses
7.9 Sunway Biotech
7.9.1 Sunway Biotech Details
7.9.2 Sunway Biotech Major Business
7.9.3 Sunway Biotech Gene-based Therapy Medicinal Product and Services
7.9.4 Sunway Biotech Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Sunway Biotech Recent Developments/Updates
7.9.6 Sunway Biotech Competitive Strengths & Weaknesses
7.10 SIBIONO
7.10.1 SIBIONO Details
7.10.2 SIBIONO Major Business
7.10.3 SIBIONO Gene-based Therapy Medicinal Product and Services
7.10.4 SIBIONO Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 SIBIONO Recent Developments/Updates
7.10.6 SIBIONO Competitive Strengths & Weaknesses
7.11 AnGes
7.11.1 AnGes Details
7.11.2 AnGes Major Business
7.11.3 AnGes Gene-based Therapy Medicinal Product and Services
7.11.4 AnGes Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 AnGes Recent Developments/Updates
7.11.6 AnGes Competitive Strengths & Weaknesses
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Details
7.12.2 Orchard Therapeutics Major Business
7.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Product and Services
7.12.4 Orchard Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Orchard Therapeutics Recent Developments/Updates
7.12.6 Orchard Therapeutics Competitive Strengths & Weaknesses
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Details
7.13.2 Human Stem Cells Institute Major Business
7.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Product and Services
7.13.4 Human Stem Cells Institute Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Human Stem Cells Institute Recent Developments/Updates
7.13.6 Human Stem Cells Institute Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene-based Therapy Medicinal Industry Chain
8.2 Gene-based Therapy Medicinal Upstream Analysis
8.3 Gene-based Therapy Medicinal Midstream Analysis
8.4 Gene-based Therapy Medicinal Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Gene-based Therapy Medicinal Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Gene-based Therapy Medicinal Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Gene-based Therapy Medicinal Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Gene-based Therapy Medicinal Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Gene-based Therapy Medicinal Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene-based Therapy Medicinal Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Gene-based Therapy Medicinal Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Gene-based Therapy Medicinal Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Gene-based Therapy Medicinal Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Gene-based Therapy Medicinal Players in 2022
Table 12. World Gene-based Therapy Medicinal Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Gene-based Therapy Medicinal Company Evaluation Quadrant
Table 14. Head Office of Key Gene-based Therapy Medicinal Player
Table 15. Gene-based Therapy Medicinal Market: Company Product Type Footprint
Table 16. Gene-based Therapy Medicinal Market: Company Product Application Footprint
Table 17. Gene-based Therapy Medicinal Mergers & Acquisitions Activity
Table 18. United States VS China Gene-based Therapy Medicinal Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Gene-based Therapy Medicinal Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Gene-based Therapy Medicinal Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Gene-based Therapy Medicinal Revenue Market Share (2018-2023)
Table 23. China Based Gene-based Therapy Medicinal Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Gene-based Therapy Medicinal Revenue Market Share (2018-2023)
Table 26. Rest of World Based Gene-based Therapy Medicinal Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Gene-based Therapy Medicinal Revenue Market Share (2018-2023)
Table 29. World Gene-based Therapy Medicinal Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Gene-based Therapy Medicinal Market Size by Type (2018-2023) & (USD Million)
Table 31. World Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (USD Million)
Table 32. World Gene-based Therapy Medicinal Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Gene-based Therapy Medicinal Market Size by Application (2018-2023) & (USD Million)
Table 34. World Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (USD Million)
Table 35. Biogen Basic Information, Area Served and Competitors
Table 36. Biogen Major Business
Table 37. Biogen Gene-based Therapy Medicinal Product and Services
Table 38. Biogen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Biogen Recent Developments/Updates
Table 40. Biogen Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Gene-based Therapy Medicinal Product and Services
Table 44. Novartis Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Gilead Sciences Basic Information, Area Served and Competitors
Table 48. Gilead Sciences Major Business
Table 49. Gilead Sciences Gene-based Therapy Medicinal Product and Services
Table 50. Gilead Sciences Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Gilead Sciences Recent Developments/Updates
Table 52. Gilead Sciences Competitive Strengths & Weaknesses
Table 53. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 54. Sarepta Therapeutics Major Business
Table 55. Sarepta Therapeutics Gene-based Therapy Medicinal Product and Services
Table 56. Sarepta Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sarepta Therapeutics Recent Developments/Updates
Table 58. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 59. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Alnylam Pharmaceuticals Major Business
Table 61. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product and Services
Table 62. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Alnylam Pharmaceuticals Recent Developments/Updates
Table 64. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Amgen Basic Information, Area Served and Competitors
Table 66. Amgen Major Business
Table 67. Amgen Gene-based Therapy Medicinal Product and Services
Table 68. Amgen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Amgen Recent Developments/Updates
Table 70. Amgen Competitive Strengths & Weaknesses
Table 71. Spark Therapeutics Basic Information, Area Served and Competitors
Table 72. Spark Therapeutics Major Business
Table 73. Spark Therapeutics Gene-based Therapy Medicinal Product and Services
Table 74. Spark Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Spark Therapeutics Recent Developments/Updates
Table 76. Spark Therapeutics Competitive Strengths & Weaknesses
Table 77. Akcea Therapeutics Basic Information, Area Served and Competitors
Table 78. Akcea Therapeutics Major Business
Table 79. Akcea Therapeutics Gene-based Therapy Medicinal Product and Services
Table 80. Akcea Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Akcea Therapeutics Recent Developments/Updates
Table 82. Akcea Therapeutics Competitive Strengths & Weaknesses
Table 83. Sunway Biotech Basic Information, Area Served and Competitors
Table 84. Sunway Biotech Major Business
Table 85. Sunway Biotech Gene-based Therapy Medicinal Product and Services
Table 86. Sunway Biotech Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sunway Biotech Recent Developments/Updates
Table 88. Sunway Biotech Competitive Strengths & Weaknesses
Table 89. SIBIONO Basic Information, Area Served and Competitors
Table 90. SIBIONO Major Business
Table 91. SIBIONO Gene-based Therapy Medicinal Product and Services
Table 92. SIBIONO Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. SIBIONO Recent Developments/Updates
Table 94. SIBIONO Competitive Strengths & Weaknesses
Table 95. AnGes Basic Information, Area Served and Competitors
Table 96. AnGes Major Business
Table 97. AnGes Gene-based Therapy Medicinal Product and Services
Table 98. AnGes Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. AnGes Recent Developments/Updates
Table 100. AnGes Competitive Strengths & Weaknesses
Table 101. Orchard Therapeutics Basic Information, Area Served and Competitors
Table 102. Orchard Therapeutics Major Business
Table 103. Orchard Therapeutics Gene-based Therapy Medicinal Product and Services
Table 104. Orchard Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Orchard Therapeutics Recent Developments/Updates
Table 106. Human Stem Cells Institute Basic Information, Area Served and Competitors
Table 107. Human Stem Cells Institute Major Business
Table 108. Human Stem Cells Institute Gene-based Therapy Medicinal Product and Services
Table 109. Human Stem Cells Institute Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of Gene-based Therapy Medicinal Upstream (Raw Materials)
Table 111. Gene-based Therapy Medicinal Typical Customers
LIST OF FIGURE
Figure 1. Gene-based Therapy Medicinal Picture
Figure 2. World Gene-based Therapy Medicinal Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene-based Therapy Medicinal Total Market Size (2018-2029) & (USD Million)
Figure 4. World Gene-based Therapy Medicinal Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene-based Therapy Medicinal Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 13. Gene-based Therapy Medicinal Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 16. World Gene-based Therapy Medicinal Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 18. China Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 23. India Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Gene-based Therapy Medicinal by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene-based Therapy Medicinal Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene-based Therapy Medicinal Markets in 2022
Figure 27. United States VS China: Gene-based Therapy Medicinal Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene-based Therapy Medicinal Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Gene-based Therapy Medicinal Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Gene-based Therapy Medicinal Market Size Market Share by Type in 2022
Figure 31. Viral Gene Delivery System
Figure 32. Non-viral Gene Delivery System
Figure 33. World Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2029)
Figure 34. World Gene-based Therapy Medicinal Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Gene-based Therapy Medicinal Market Size Market Share by Application in 2022
Figure 36. Neurological Diseases
Figure 37. Cancer
Figure 38. Other
Figure 39. Gene-based Therapy Medicinal Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Gene-based Therapy Medicinal Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Gene-based Therapy Medicinal Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Gene-based Therapy Medicinal Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Gene-based Therapy Medicinal Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Gene-based Therapy Medicinal Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene-based Therapy Medicinal Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Gene-based Therapy Medicinal Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Gene-based Therapy Medicinal Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Gene-based Therapy Medicinal Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Gene-based Therapy Medicinal Players in 2022
Table 12. World Gene-based Therapy Medicinal Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Gene-based Therapy Medicinal Company Evaluation Quadrant
Table 14. Head Office of Key Gene-based Therapy Medicinal Player
Table 15. Gene-based Therapy Medicinal Market: Company Product Type Footprint
Table 16. Gene-based Therapy Medicinal Market: Company Product Application Footprint
Table 17. Gene-based Therapy Medicinal Mergers & Acquisitions Activity
Table 18. United States VS China Gene-based Therapy Medicinal Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Gene-based Therapy Medicinal Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Gene-based Therapy Medicinal Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Gene-based Therapy Medicinal Revenue Market Share (2018-2023)
Table 23. China Based Gene-based Therapy Medicinal Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Gene-based Therapy Medicinal Revenue Market Share (2018-2023)
Table 26. Rest of World Based Gene-based Therapy Medicinal Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene-based Therapy Medicinal Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Gene-based Therapy Medicinal Revenue Market Share (2018-2023)
Table 29. World Gene-based Therapy Medicinal Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Gene-based Therapy Medicinal Market Size by Type (2018-2023) & (USD Million)
Table 31. World Gene-based Therapy Medicinal Market Size by Type (2024-2029) & (USD Million)
Table 32. World Gene-based Therapy Medicinal Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Gene-based Therapy Medicinal Market Size by Application (2018-2023) & (USD Million)
Table 34. World Gene-based Therapy Medicinal Market Size by Application (2024-2029) & (USD Million)
Table 35. Biogen Basic Information, Area Served and Competitors
Table 36. Biogen Major Business
Table 37. Biogen Gene-based Therapy Medicinal Product and Services
Table 38. Biogen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Biogen Recent Developments/Updates
Table 40. Biogen Competitive Strengths & Weaknesses
Table 41. Novartis Basic Information, Area Served and Competitors
Table 42. Novartis Major Business
Table 43. Novartis Gene-based Therapy Medicinal Product and Services
Table 44. Novartis Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Novartis Recent Developments/Updates
Table 46. Novartis Competitive Strengths & Weaknesses
Table 47. Gilead Sciences Basic Information, Area Served and Competitors
Table 48. Gilead Sciences Major Business
Table 49. Gilead Sciences Gene-based Therapy Medicinal Product and Services
Table 50. Gilead Sciences Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Gilead Sciences Recent Developments/Updates
Table 52. Gilead Sciences Competitive Strengths & Weaknesses
Table 53. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 54. Sarepta Therapeutics Major Business
Table 55. Sarepta Therapeutics Gene-based Therapy Medicinal Product and Services
Table 56. Sarepta Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sarepta Therapeutics Recent Developments/Updates
Table 58. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 59. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Alnylam Pharmaceuticals Major Business
Table 61. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product and Services
Table 62. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Alnylam Pharmaceuticals Recent Developments/Updates
Table 64. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Amgen Basic Information, Area Served and Competitors
Table 66. Amgen Major Business
Table 67. Amgen Gene-based Therapy Medicinal Product and Services
Table 68. Amgen Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Amgen Recent Developments/Updates
Table 70. Amgen Competitive Strengths & Weaknesses
Table 71. Spark Therapeutics Basic Information, Area Served and Competitors
Table 72. Spark Therapeutics Major Business
Table 73. Spark Therapeutics Gene-based Therapy Medicinal Product and Services
Table 74. Spark Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Spark Therapeutics Recent Developments/Updates
Table 76. Spark Therapeutics Competitive Strengths & Weaknesses
Table 77. Akcea Therapeutics Basic Information, Area Served and Competitors
Table 78. Akcea Therapeutics Major Business
Table 79. Akcea Therapeutics Gene-based Therapy Medicinal Product and Services
Table 80. Akcea Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Akcea Therapeutics Recent Developments/Updates
Table 82. Akcea Therapeutics Competitive Strengths & Weaknesses
Table 83. Sunway Biotech Basic Information, Area Served and Competitors
Table 84. Sunway Biotech Major Business
Table 85. Sunway Biotech Gene-based Therapy Medicinal Product and Services
Table 86. Sunway Biotech Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Sunway Biotech Recent Developments/Updates
Table 88. Sunway Biotech Competitive Strengths & Weaknesses
Table 89. SIBIONO Basic Information, Area Served and Competitors
Table 90. SIBIONO Major Business
Table 91. SIBIONO Gene-based Therapy Medicinal Product and Services
Table 92. SIBIONO Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. SIBIONO Recent Developments/Updates
Table 94. SIBIONO Competitive Strengths & Weaknesses
Table 95. AnGes Basic Information, Area Served and Competitors
Table 96. AnGes Major Business
Table 97. AnGes Gene-based Therapy Medicinal Product and Services
Table 98. AnGes Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. AnGes Recent Developments/Updates
Table 100. AnGes Competitive Strengths & Weaknesses
Table 101. Orchard Therapeutics Basic Information, Area Served and Competitors
Table 102. Orchard Therapeutics Major Business
Table 103. Orchard Therapeutics Gene-based Therapy Medicinal Product and Services
Table 104. Orchard Therapeutics Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Orchard Therapeutics Recent Developments/Updates
Table 106. Human Stem Cells Institute Basic Information, Area Served and Competitors
Table 107. Human Stem Cells Institute Major Business
Table 108. Human Stem Cells Institute Gene-based Therapy Medicinal Product and Services
Table 109. Human Stem Cells Institute Gene-based Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of Gene-based Therapy Medicinal Upstream (Raw Materials)
Table 111. Gene-based Therapy Medicinal Typical Customers
LIST OF FIGURE
Figure 1. Gene-based Therapy Medicinal Picture
Figure 2. World Gene-based Therapy Medicinal Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene-based Therapy Medicinal Total Market Size (2018-2029) & (USD Million)
Figure 4. World Gene-based Therapy Medicinal Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene-based Therapy Medicinal Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Gene-based Therapy Medicinal Revenue (2018-2029) & (USD Million)
Figure 13. Gene-based Therapy Medicinal Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 16. World Gene-based Therapy Medicinal Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 18. China Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 23. India Gene-based Therapy Medicinal Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Gene-based Therapy Medicinal by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene-based Therapy Medicinal Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene-based Therapy Medicinal Markets in 2022
Figure 27. United States VS China: Gene-based Therapy Medicinal Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene-based Therapy Medicinal Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Gene-based Therapy Medicinal Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Gene-based Therapy Medicinal Market Size Market Share by Type in 2022
Figure 31. Viral Gene Delivery System
Figure 32. Non-viral Gene Delivery System
Figure 33. World Gene-based Therapy Medicinal Market Size Market Share by Type (2018-2029)
Figure 34. World Gene-based Therapy Medicinal Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Gene-based Therapy Medicinal Market Size Market Share by Application in 2022
Figure 36. Neurological Diseases
Figure 37. Cancer
Figure 38. Other
Figure 39. Gene-based Therapy Medicinal Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
